- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bio-Techne Corp DRC (T1CH34)
Assess today's live Bio-Techne Corp DRC (T1CH34) share price, performance and insights using our live B3: T1CH34 stock exchange data.
Analyse the historical data and Bio-Techne Corp DRC share price performance charts on this page. Our technical summary section provides analysis on BioTechne share price buy/sell indicators using real-time data (or discuss the BioTechne (T1CH34) stock price today with other investors in the BioTechne BVMF share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current BVMF T1CH34 share price (ISIN: BRT1CHBDR003) to enhance your trading decisions with our free investment tools and resources.
What Is the Bio-Techne Corp DRC Share Price Today?
The BioTechne share price today is 11.07.
What Is the Stock Symbol for Bio-Techne Corp DRC
The stock symbol (or 'ticker') for Bio-Techne Corp DRC is "T1CH34."
What Stock Exchange Does Bio-Techne Corp DRC Trade On?
Bio-Techne Corp DRC is listed and trades on the B3 stock exchange.
Is Bio-Techne Corp DRC a Good Stock to Buy?
Determining whether Bio-Techne Corp DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Bio-Techne Corp DRC share price performance charts on this page. Our technical summary section provides analysis on BioTechne share price buy/sell indicators using real-time data (or discuss the BioTechne (T1CH34) stock price today with other investors in the BioTechne BVMF share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current BVMF T1CH34 share price (ISIN: BRT1CHBDR003) to enhance your trading decisions with our free investment tools and resources.
What Is the Bio-Techne Corp DRC Share Price Today?
The BioTechne share price today is 11.07.
What Is the Stock Symbol for Bio-Techne Corp DRC
The stock symbol (or 'ticker') for Bio-Techne Corp DRC is "T1CH34."
What Stock Exchange Does Bio-Techne Corp DRC Trade On?
Bio-Techne Corp DRC is listed and trades on the B3 stock exchange.
Is Bio-Techne Corp DRC a Good Stock to Buy?
Determining whether Bio-Techne Corp DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
11.07
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.07
11.07
52 wk Range
8.92
12.70
T1CH34 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.0711.07
52 wk Range
8.9212.70
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.34%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.34%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
T1CH34 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Techne Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Techne Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Techne Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Techne Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
BioTechne Company Profile
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Compare T1CH34 to Peers and Sector
Metrics to compare | T1CH34 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipT1CH34PeersSector | |
|---|---|---|---|---|
P/E Ratio | 114.4x | 21.2x | −0.5x | |
PEG Ratio | −2.41 | 0.06 | 0.00 | |
Price/Book | 4.6x | 2.5x | 2.6x | |
Price / LTM Sales | 7.6x | 3.8x | 3.3x | |
Upside (Analyst Target) | - | 503.5% | 46.0% | |
Fair Value Upside | Unlock | 17.6% | 5.4% | Unlock |
Earnings
Latest Release
Feb 04, 2026
EPS / Forecast
0.24 / --
Revenue / Forecast
295.88M / --
FAQ
What Is the BioTechne (T1CH34) Share Price Today?
The live BioTechne share price today is 11.07
What Stock Exchange Does BioTechne (T1CH34) Trade On?
BioTechne is listed and trades on the B3 Stock Exchange.
What Is the Ticker (Stock Symbol) for BioTechne?
The stock symbol (also called a 'ticker') for BioTechne is "T1CH34."
Does BioTechne Pay Dividends? What’s The Current T1CH34 Dividend Yield?
Yes, T1CH34 Pays Dividends to its Shareholders. The current BioTechne dividend yield is 0.34%.
What Is the Current BioTechne Market Cap?
As of today, BioTechne market capitalisation is 48.72B.
What Is BioTechne's (T1CH34) Earnings Per Share (TTM)?
The BioTechne EPS is currently 0.52 (Trailing Twelve Months).
Is T1CH34 a Buy or Sell From a Technical Analyst Perspective?
Based on today's BioTechne moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has BioTechne Stock Split?
BioTechne has split 1 times. (See the T1CH34 stock split history page for full effective split date and price information.)
How Many Employees Does BioTechne Have?
BioTechne has 3100 employees.
What is the current trading status of BioTechne (T1CH34)?
As of 18/02/2026, BioTechne (T1CH34) is trading at a price of 11.07, with a previous close of 11.08. The stock has fluctuated within a day range of 11.07 to 11.07, while its 52-week range spans from 8.92 to 12.70.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.